KAWASAKI DISEASE
Clinical trials for KAWASAKI DISEASE explained in plain language.
Never miss a new study
Get alerted when new KAWASAKI DISEASE trials appear
Sign up with your email to follow new studies for KAWASAKI DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to shield Kids' hearts from kawasaki damage
Disease control CompletedThis early-phase study tested a combination of atorvastatin and anakinra in 5 children with Kawasaki disease who had coronary artery abnormalities. The goal was to see if these drugs could safely reduce artery inflammation and prevent long-term heart damage. The study focused on …
Matched conditions: KAWASAKI DISEASE
Phase: EARLY_PHASE1 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated May 26, 2026 05:27 UTC
-
Steroid combo shields Kids' hearts from kawasaki damage
Disease control CompletedThis study tested whether adding the steroid prednisolone to the usual treatment (immunoglobulin and aspirin) could reduce heart artery damage in children with Kawasaki disease. Over 3,200 children were enrolled within 10 days of fever onset. The main goal was to see if the combi…
Matched conditions: KAWASAKI DISEASE
Phase: PHASE3 • Sponsor: Children's Hospital of Fudan University • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Kawasaki Kids' hearts under the microscope 5 years later
Knowledge-focused CompletedThis study looked at the heart and blood vessel health of 61 children who had Kawasaki disease 5 years earlier and were treated with IVIG. Researchers compared them to healthy children using blood tests, blood pressure measurements, and heart scans. The goal was to find early sig…
Matched conditions: KAWASAKI DISEASE
Sponsor: Medical University of Warsaw • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC